Navigation Links
EPGL Technology Selected by Major Corporation for Development
Date:12/16/2013

IRVINE, Calif., Dec. 16, 2013 /PRNewswire/ -- EP Global Communications, Inc., (OTC Ticker EPGL) makes the following announcement:

In a first for the company, one of EPGL's advanced technologies has been selected by a multi-billion dollar, NYSE publicly traded industry leader for development and integration into new products.

The Development Agreement was signed last week, being the week of December 8, 2013.

"This is the biggest development for our company in its history,"  said David T. Markus PhD.  "This is just the first of many possible Agreements to come for EPGL and its advanced technologies.  EPGL is a leader in BioMEMS technology and the companies we develop with will become leaders as well in this field for their particular products."

The two companies have signed a confidentiality agreement due to the sensitive and competitive nature of the technology.  Details of the first Development Agreement will remain confidential for now.  However, PwC as custodian for AJW Funds Board membership of EPGL has been apprised of the Agreement and its details.

EPGL currently has over 15 new advanced technologies and corporations in the medical device and consumer electronics fields have sought to enter relationship with the company.  Because of this development, EPGL intends to expand upon and focus on this business model going forward. 

EPGL Management and Team would like to wish all of our shareholders a Merry Christmas, Happy Hanukkah and Happy New Year.

About EP Global Communications, Inc.
EP Global Communications, Inc. is an advanced technology development company for both medical devices and consumer electronics.  EPGL also holds an FDA 510k cleared medical device called the MPD1. The MPD1 is a revolutionary new diagnostic and therapeutic tool for the muscular originated pain in the human body.

Safe Harbor Statement
Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.


'/>"/>
SOURCE EP Global Communications, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. First And Only Skincare To Use Plant And Human Adult Stem Cell Technology Launches
2. Oramed Receives Allowance on its Core Oral GLP-1 Technology Patent in Israel
3. Lincor Upgrades Patient Engagement Technology, Launches New Product Portfolio
4. Frost & Sullivan Applauds Definiens Strong Technology Portfolio for the Effective Data Analysis of Histology Images
5. Dividends, Recognitions, Positive Opinions, Share Repurchase Programs, and Award Programs - Research Report on BD, Sanofi, GSK, Agilent Technologies, and Align Technology
6. The OR Company Acquires Rights to Baltimore-Based Start-Up Technology
7. Drug Solubility Technology: Spray Drying, Extrusion, and SCF
8. Orcasonix Unveils Innovative Ultrasound Technology Built on Cephasonics cQuest Family of Ultrasound Systems
9. Cincinnati Childrens Issued Patent Covering Individualized Medication Dosing Technology
10. Technology & Innovation Transforming Pharmaceutical Sales Training Programs
11. 3D Printing, the Disruptive Technology for World Manufacturing has a New Patent Granted to Renowned Inventor Donald Spector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
(Date:6/23/2016)... , June 23, 2016 ... Oticon , industry leaders in advanced ... launch of Oticon Opn ™, the world,s first ... of possibilities for IoT devices.      (Photo: ... Oticon introduces a number of ,world firsts,: ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) sponsors ... on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, ... to helping service members that have been wounded in battle and their families. Venture ...
Breaking Medicine News(10 mins):